IL175649A0 - Novel method of preparing 3-fluorinated quinolines - Google Patents

Novel method of preparing 3-fluorinated quinolines

Info

Publication number
IL175649A0
IL175649A0 IL175649A IL17564906A IL175649A0 IL 175649 A0 IL175649 A0 IL 175649A0 IL 175649 A IL175649 A IL 175649A IL 17564906 A IL17564906 A IL 17564906A IL 175649 A0 IL175649 A0 IL 175649A0
Authority
IL
Israel
Prior art keywords
alkyl
quinolines
optionally substituted
protecting group
fluorinated
Prior art date
Application number
IL175649A
Other versions
IL175649A (en
Original Assignee
Novexel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novexel filed Critical Novexel
Publication of IL175649A0 publication Critical patent/IL175649A0/en
Publication of IL175649A publication Critical patent/IL175649A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18Halogen atoms or nitro radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J23/00Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
    • B01J23/38Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
    • B01J23/40Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals of the platinum group metals
    • B01J23/44Palladium
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/02Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Oncology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)

Abstract

Preparation of 3-fluoro-quinolines (I) (optionally substituted in the 5-, 6-, 7- and/or 8-position) involves heating a corresponding quinoline-3-diazonium tetrafluoroborate (II) in an inert organic solvent. Preparation of 3-fluoro-quinolines of formula (I) involves heating a quinoline-3-diazonium tetrafluoroborate of formula (II) in an inert organic solvent. [Image] R 1 - R 4H or F; linear, branched or cyclic alkyl (optionally substituted by 1-3 F, by OR 5 or by NR'R''); OR 6, NR' 1R'' 1 or COOR a; or phenyl or heteroaryl, both optionally substituted by one or more of the substituents given above or below; R 5H, alkyl or hydroxy-protecting group; R', R'' : H, alkyl or amino-protecting group; R 6H, phenol protecting group or alkyl (optionally substituted by 1-3 F, by OR 5 or by NR'R''); R' 1, R'' 1as for R', R''; or alkyl substituted by 1-3 F, by OR 5 or by NR'R''; and R aH, alkyl or carboxy-protecting group. An independent claim is included for (II) as new compounds.
IL175649A 2003-11-17 2006-05-15 Process for preparing 3-fluorinated quinolines and novel intermediates in the process IL175649A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0313384A FR2862301B1 (en) 2003-11-17 2003-11-17 NEW PROCESS FOR THE PREPARATION OF 3-FLUORINATED QUINOLINES
PCT/FR2004/002910 WO2005049575A1 (en) 2003-11-17 2004-11-15 Novel method of preparing 3-fluorinated quinolines

Publications (2)

Publication Number Publication Date
IL175649A0 true IL175649A0 (en) 2006-09-05
IL175649A IL175649A (en) 2011-01-31

Family

ID=34508487

Family Applications (1)

Application Number Title Priority Date Filing Date
IL175649A IL175649A (en) 2003-11-17 2006-05-15 Process for preparing 3-fluorinated quinolines and novel intermediates in the process

Country Status (18)

Country Link
EP (1) EP1687276B1 (en)
JP (1) JP4751333B2 (en)
KR (1) KR20060123161A (en)
CN (1) CN100537540C (en)
AT (1) ATE445605T1 (en)
AU (1) AU2004291376A1 (en)
CA (1) CA2542796C (en)
DE (1) DE602004023640D1 (en)
ES (1) ES2334796T3 (en)
FR (1) FR2862301B1 (en)
HK (1) HK1099020A1 (en)
HR (1) HRP20060168A2 (en)
IL (1) IL175649A (en)
IS (1) IS8423A (en)
MX (1) MXPA06005599A (en)
NO (1) NO20062761L (en)
RU (1) RU2351591C2 (en)
WO (1) WO2005049575A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7396934B2 (en) 2003-11-17 2008-07-08 Youssef El-Ahmad Process for preparing 3-fluoroquinolines
EP2389376A1 (en) 2009-01-21 2011-11-30 Basilea Pharmaceutica AG Novel bicyclic antibiotics
CN104672131B (en) * 2013-11-27 2017-03-15 中国科学院大连化学物理研究所 A kind of method of 3 fluorine quinolines of synthesis

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA801526B (en) * 1979-03-26 1981-08-26 Robins Co Inc A H 4-amino-3-quinolinecarboxylic acids and esters-antisecretory, anti-ulcer compounds
DE3620856A1 (en) * 1986-06-21 1987-12-23 Basf Ag 3-CYANCHINOLINE DERIVATIVES
DK273689A (en) * 1988-06-06 1989-12-07 Sanofi Sa 4-AMINO-3-CARBOXYQUINOLINES AND -NAPHTHYRIDINES, PROCEDURES FOR THEIR PREPARATION AND USE OF THEM IN PHARMACEUTICALS
JPH06287187A (en) * 1993-04-02 1994-10-11 Nippon Soda Co Ltd New pyrazole derivative and its abricultural and horticultural germicide
SE0004056D0 (en) * 2000-11-06 2000-11-06 Astrazeneca Ab N-type calcium channel antagonists for the treatment of pain
FR2816618B1 (en) * 2000-11-15 2002-12-27 Aventis Pharma Sa HETEROCYCLYLALCOYL PIPERIDINE DERIVATIVES, THEIR PREPARATION AND THE COMPOSITIONS CONTAINING THEM
FR2822154B1 (en) * 2001-03-13 2005-10-21 Aventis Pharma Sa QUINOLYL PROPYL PIPERIDINE DERIVATIVES, THEIR PREPARATION AND THE COMPOSITIONS CONTAINING THEM
TWI275390B (en) * 2002-04-30 2007-03-11 Wyeth Corp Process for the preparation of 7-substituted-3- quinolinecarbonitriles

Also Published As

Publication number Publication date
WO2005049575A1 (en) 2005-06-02
DE602004023640D1 (en) 2009-11-26
IL175649A (en) 2011-01-31
AU2004291376A1 (en) 2005-06-02
EP1687276A1 (en) 2006-08-09
ES2334796T3 (en) 2010-03-16
CA2542796C (en) 2011-08-02
JP4751333B2 (en) 2011-08-17
HRP20060168A2 (en) 2006-09-30
RU2351591C2 (en) 2009-04-10
FR2862301B1 (en) 2007-12-21
IS8423A (en) 2006-04-21
CN1894216A (en) 2007-01-10
ATE445605T1 (en) 2009-10-15
CA2542796A1 (en) 2005-06-02
MXPA06005599A (en) 2007-01-26
KR20060123161A (en) 2006-12-01
HK1099020A1 (en) 2007-08-03
RU2006120275A (en) 2008-01-10
FR2862301A1 (en) 2005-05-20
NO20062761L (en) 2006-08-17
EP1687276B1 (en) 2009-10-14
CN100537540C (en) 2009-09-09
JP2007511490A (en) 2007-05-10

Similar Documents

Publication Publication Date Title
NO20051051L (en) Derivatives of dioxane-2-alkylcarbamates, processes for their preparation and use of the same in therapeutic agents
CA2161542A1 (en) Novel 5-Pyrrolyl-2-Pyridylmethylsulfinyl Benzimidazole Derivatives
AU3599701A (en) Fluorescent probes for the quantitation of zinc
WO1997047270A3 (en) Novel anti-viral compounds
NO995711L (en) Quinoline-4-carboxamide derivatives such as NK-2 and NK-3 receptor antagonists
UA87301C2 (en) Method of producing aminophenol compounds
IL181196A0 (en) Methods for the production of isoindole derivatives
HK1099020A1 (en) Method of preparing 3-fluorinated quinolines
MXPA04002569A (en) Spirocyclic-6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines.
DK2213664T3 (en) PROCEDURE FOR THE PREPARATION OF CYCLOPENTA [G] QUINAZOLINE DERIVATIVES
ATE370736T1 (en) METHOD FOR PRODUCING A PIPERAZINE DERIVATIVE
EA200001101A1 (en) NEW DIHYDROFURO [3,4-b] QUINOLIN-1-ONE, METHOD OF THEIR PRODUCTION AND CONTAINING THEIR PHARMACEUTICAL COMPOSITIONS
RU94033098A (en) Process for preparing 1-substituted-5-(4h) tetrazolinone derivatives
ATE376830T1 (en) BENZO(B(THIOPHENE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF
WO2003029254A1 (en) Process for preparation of tricyclic compounds
EA200301171A1 (en) NEW CONCENTRATIONS OF TRICYCLIC DIHYDROCHINOLINES, METHOD OF THEIR RECOVERY AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
PT1165543E (en) Process for the preparation of acetic acid (R *, S *) | -BETA-¬¬-1-OXO-3- (4-PIPERIDINYL) PROPYL-3-PIPERIDINYL-CARBONYL AMINO 3-PYRIDINOPROPANOIC ACID AND DERIVATIVES
YU3099A (en) Novel erythromycine derivatives, procedure for production and application thereof
WO2002060878A1 (en) Benzimidazolidinone derivatives
EE05136B1 (en) Method for the preparation of substituted imidazopidine compounds
BG103398A (en) New derivatives of erythromicyn, method for their preparation and application as medicmentous forms
WO2001085692A3 (en) An improved process for the preparation of quinolone derivatives
DE60103752D1 (en) METHOD FOR THE PRODUCTION OF PYRAZOLOPYRIDINE DERIVATIVES
EP1780203A3 (en) Enantioselective alkylation of tricyclic compounds
HU0001727D0 (en) Novel 1-aza-2-alkyl-6-aryl-cycloalkane compounds, process for producing them and medicaments containing the same

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees